Finance

Lists
SBS:ETR
Stratec SE
23,20 €
+1,31%
(+0,30) 1D
12 ოქტ, 13:53:02 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SBS...
Open
23,00 €
High
23,30 €
Low
23,00 €
Mkt. cap
282,06 მლნ.
Avg. vol.
13,74 ათ.
Volume
8,58 ათ.
Dividend
2,59%
Quarterly dividend
0,15 €
Ex-dividend date
24 ივნ. 2026
52-wk high
30,50 €
52-wk low
16,30 €
EPS
-0,03 €
Shares outstanding
12,16 მლნ.
No. of employees
1 ათ.
Open
23,00 €
High
23,30 €
Low
23,00 €
Mkt. cap
282,06 მლნ.
Avg. vol.
13,74 ათ.
Volume
8,58 ათ.
Dividend
2,59%
Quarterly dividend
0,15 €
Ex-dividend date
24 ივნ. 2026
52-wk high
30,50 €
52-wk low
16,30 €
EPS
-0,03 €
Shares outstanding
12,16 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
STRATEC SE is a company with worldwide operations that designs and manufactures fully automated analyzer systems for partners in clinical diagnostics and biotechnology - particularly in the field of in-vitro-diagnostics. As a classic original equipment manufacturer supplier, STRATEC produces its systems almost exclusively on behalf of its customers. Alongside the systems themselves, the company also provides sample preparation solutions, system software and integrated laboratory software. STRATEC is also responsible for development documentation, testing, delivery of systems, and the supply of spare parts and complex consumables for diagnostic and medical applications. STRATEC's customers are well known diagnostic companies like DiaSorin, Abbott, SIEMENS, Bio-Rad or Hologic. Wikipedia
About Stratec SE
CEO-
Employees1,38 ათ.
Founded1979
Headquarters-
SectorMedical device
Last report
14 აგვ. 2026
Fiscal period
Q2 2026
- / -
Revenue / Est. (EUR)
59,11 მლნ. / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
57,00 მლნ.
75,28 მლნ.
53,43 მლნ.
59,11 მლნ.
Cost of goods sold
43,70 მლნ.
56,31 მლნ.
43,22 მლნ.
43,87 მლნ.
Cost of revenue
43,70 მლნ.
56,31 მლნ.
43,22 მლნ.
43,87 მლნ.
Research and development expenses
1,59 მლნ.
2,78 მლნ.
1,72 მლნ.
1,49 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,47 მლნ.
10,82 მლნ.
8,82 მლნ.
9,64 მლნ.
Operating expense
9,78 მლნ.
11,19 მლნ.
10,30 მლნ.
9,66 მლნ.
Total operating expenses
53,48 მლნ.
67,50 მლნ.
53,53 მლნ.
53,54 მლნ.
Operating income
3,52 მლნ.
7,78 მლნ.
-104,00 ათ.
5,57 მლნ.
Other non operating income
-117,00 ათ.
219,00 ათ.
-65,00 ათ.
61,00 ათ.
EBT including unusual items
2,38 მლნ.
-826,00 ათ.
-1,16 მლნ.
5,43 მლნ.
EBT excluding unusual items
2,38 მლნ.
5,55 მლნ.
-1,16 მლნ.
5,43 მლნ.
Income tax expense
878,00 ათ.
3,52 მლნ.
557,00 ათ.
1,27 მლნ.
Effective tax rate
36,91%
-426,03%
-48,18%
23,35%
Other operating expenses
-274,00 ათ.
-2,41 მლნ.
-235,00 ათ.
-1,46 მლნ.
Net income
1,50 მლნ.
-4,34 მლნ.
-1,71 მლნ.
4,16 მლნ.
Net profit margin
2,63%
-5,77%
-3,21%
7,04%
Earnings per share
-
-
-
-
Interest and investment income
33,00 ათ.
8,00 ათ.
34,00 ათ.
55,00 ათ.
Interest expense
-1,06 მლნ.
-955,00 ათ.
-1,02 მლნ.
-260,00 ათ.
Net interest expenses
-1,02 მლნ.
-947,00 ათ.
-987,00 ათ.
-205,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
8,04 მლნ.
10,71 მლნ.
4,45 მლნ.
10,03 მლნ.
Gain or loss from assets sale
13,00 ათ.
3,00 ათ.
-94,00 ათ.
-9,00 ათ.
AI content may include mistakes. Learn more
Google აპები